Epitheliopathy, Acute Posterior Multifocal Placoid Pigment
Epitheliopathy, Acute Posterior Multifocal Placoid Pigment
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Epitheliopathy, Acute Posterior Multifocal Placoid Pigment is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Acute multifocal placoid pigment epitheliopathy
- Acute placoid pigment epitheliopathy
- Multifocal placoid pigment epitheliopathy
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Diffuse Unilateral Subacute Neuroretinitis
- Multifocal Choroidopathy Syndromes
- Retinitis Pigmentosa
- Serpiginous choroiditis
- White Dot Syndromes
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare eye disorder of unknown (idiopathic) cause. The disorder is characterized by the impairment of central vision in one eye (unilateral) but, within a few days, the second eye may also become affected (bilateral). In most cases, the disorder resolves within a few weeks without loss of clearness of vision (acuity). However, in some cases, visual acuity does not improve. This disorder occurs predominantly in young adults, with a mean age of onset of 27 years. It is reported that, in approximately one-third of the cases, an influenza-like illness preceded the development of the disorder.
Prior to the onset of disease, about 33% of patients present with flu-like or viral symptoms such as fever, swollen lymph glands, nausea, vomiting, joint pain and/or tenderness. Moderate to severe headaches may also be present and, much more rarely, there may be neurological signs such as temporary loss of speech (aphasia) and/or weakness of the arms and legs.
In the early stages of APMPPE, patients notice areas of visual blotchiness within the field of clear vision (blotchy scotomata), flashes of light (photopsia) caused by irritation of the retina, distortion of the shapes of objects (metamorphopsia), increased sensitivity to light (photophobia) and conjunctivitis.
During the late stages of the disorder, patients usually notice mild decreases in vision. Rarely, the impaired vision may be severe.
Examination of the eye usually shows multiple flat, yellow-white lesions of the posterior pole of the nerve-rich membrane lining the eyes (retina). Frequently the veins of the retina are inflamed (vasculitis), but the inflammation often subsides without treatment. In some cases, pigment changes in the retina may be permanent and the resulting visual impairment may also be permanent. However, in most cases the disorder is characterized by a temporary impairment of vision.
The exact cause of acute posterior multifocal placoid pigment epitheliopathy is not known. Researchers suspect that it may be caused by a virus. It can subside without treatment or it may recur at any time. The viruses may stay dormant in humans for extended periods of time, then for reasons yet unknown may unexplainably become reactivated.
Acute posterior multifocal placoid pigment epitheliopathy is a rare visual disorder that affects males and females in equal numbers.
Symptoms of the following disorders can be similar to those of acute posterior multifocal placoid pigment epitheliopathy. Comparison may be useful for a differential diagnosis:
Diffuse unilateral subacute neuroretinitis (DUSN) is a progressive parasitic disease affecting the outer retina and retinal pigment epithelium (RPE). This syndrome is primarily unilateral, although bilateral cases have occurred. Examination of the eye shows visual loss, vitreous cells, optic disc inflammation and leakage, and transient, but recurrent, crops of gray-white outer retinal lesions.
Stationary or migrating parasitic worms (nematodes) have been identified deep in the retina or in the subretinal space. Later in the course of the disease, slowly progressive RPE changes and optic atrophy may be observed, as well as narrowing of the retinal vessels.
Multifocal choroidopathy syndromes are a group of rare disorders involving a major pathological change at or near the level of the retinal pigment epithelium (RPE) with or without inflammation of the blood vessels in the choroid layer of the eye. The cause is unclear but is thought to be either an obstruction of the blood vessels feeding the choroid layer or, possibly, an immunologic response directed at the RPE itself. Many clinical features of these individual entities overlap, causing much confusion. Whether these conditions represent distinct entities or whether some may be parts of a spectrum of the same basic disease is still unknown.
Retinitis pigmentosa (RP) is one of a group of inherited diseases causing degeneration of the retina. When the retina degenerates, as in retinitis pigmentosa, the vision decreases and may occasionally be lost. One of the earliest symptoms is difficulty seeing at night or in dimly lit places. This is slowly followed by tunnel vision. The rate and extent of progression is extremely variable, but RP does not occur with the sudden onset of APMPPE. (For more information on this disorder, choose "Retinitis Pigmentosa" as your search term in the Rare Disease Database.)
Serpiginous choroiditis, also called geographic helicoid peripapillary choroidopathy, is a rare, inflammatory disease of unknown cause (idiopathic) affecting the inner choroid and retinal pigment epithelium. Typically serpiginous choroiditis occurs bilaterally and is almost always progressive. Though longstanding remissions can be achieved through aggressive immunosuppressive therapy, patients not receiving such therapy often suffer through multiple flare-ups and are often left with macular scarring and significant visual loss.
The white dot syndromes are a group of idiopathic multifocal inflammatory conditions involving the retina and the choroid. They are characterized by the appearance of white dots in the fundus. The diseases that constitute the white dot syndromes include acute posterior multifocal placoid pigment epitheliopathy (APMPPE), serpiginous choroiditis, multiple evanescent white dot syndrome (MEWDS), multifocal choroiditis and panuveitis (MCP), punctate inner choroidopathy (PIC), and diffuse subretinal fibrosis (DSF). Presumed ocular histoplasmosis syndrome (POHS) and birdshot retinochoroidopathy are additional white dot syndromes.
Treatment of acute posterior multifocal placoid pigment epitheliopathy is symptomatic and supportive. Very often vision returns without specific treatment.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Kanski JJ, ed. Clinical Ophthalmology. 4th ed. Butterworth-Heinemann. Oxford, UK; 1999:170.
Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: an evidence-based update. Opthalmology. 2003;81:15-21.
Daniele S, Daniele C, Orcidi F, et al. Progression of choroidal atrophy in acute posterior multifocal placoid pigment epitheliopathy. Ophthalmologica. 1998;212:66-72.
Uthman I, Najjar DM, Kanj SS, et al. Anticardiolipin antibodies in acute multifocal posterior placoid pigment epitheliopathy. Ann Rheum Dis. 2003;62:687-88.
Thomson SP, Roxburgh ST. Acute posterior multifocal placoid pigment epitheliopathy associated with adenovirus infection. Eye. 2003;17:542-44.
Hsu CT, Harlan JB, Goldberg MF, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with a systemic necrotizing vasculitis. Retina. 2003;23:64-68.
Muirhead PG. Acute posterior multifocal placoid pigment epitheliopathy (APMPPE). Clin Exp Optom. 1998;81:203-04.
Di Crecchio L, Parodi MB, Saviano S, et al. Acute posterior multifocal placoid pigment epitheliopathy and ulcerative colitis: a possible association. Acta Ophthalmol Scand. 2001;79:319-21.
Cimino L, Auer C, Herbort CP. Sensitivity of indocyanine green angiography for the follow-up of active inflammatory chorio-capillaropathies. Ocul Immunol Inflamm. 2000;8:275-83.
De Souza S, Aslanides IM, Altomare F. Acute posterior multifocal placoid pigment epitheliopathy associated with retinal vasculitis, neovacularization and subhyaloid hemorrhage. Can J Ophthalmol. 1999;34:343-45.
FROM THE INTERNET
Ganley JP, Kooragayala LM. Acute multifocal placoid pigment epithelio-pathy. EMedicine. Last Updated: August 22, 2001. 14pp.
111 E 59th St
New York, NY 10022-1202
NIH/National Eye Institute
31 Center Dr
Bethesda, MD 20892-2510
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 4/25/2008
Copyright 1989, 1997, 2003 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.